Man­u­fac­tur­ing roundup: Eu­roAPI to ac­quire oligonu­cleotide mak­er for $10M+; EU na­tions face Trulic­i­ty short­age

Eu­roAPI will ac­quire Ger­man-based BianoGMP, a con­tract man­u­fac­tur­er of oligonu­cleotides, for €10 mil­lion, or $10.9 mil­lion.

Found­ed in 2017, BianoGMP main­ly fo­cus­es on pro­duc­ing oligonu­cleotides for cus­tomers do­ing pre-clin­i­cal or Phase I work. Eu­roAPI is pur­chas­ing the com­pa­ny as it is boost­ing its oligonu­cleotide pro­duc­tion busi­ness. Last year, Eu­roAPI said it was spend­ing €18 mil­lion, or $19.5 mil­lion, for new equip­ment at its man­u­fac­tur­ing site in Frank­furt to pro­duce around 500 kilo­grams of oligonu­cleotides per year by 2025.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER